BVF PARTNERS L P/IL

PrivateCIK: 1055947
Location

SAN FRANCISCO, CA

BVF PARTNERS L P/IL sold 78.3% of their position (3.75M shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market

Open‑market sale worth $62.96M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales
InsiderBVF PARTNERS L P/ILCIK 1055947
→
IssuerMOONLAKE IMMUNOTHERAPEUTICSCIK 1821586
Director10% Owner
Since Apr 2022
-3.75M
Net shares
Net seller
$62.96M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.75M disposed
Non-Derivative Transactions3

Class A Ordinary Shares, $0.0001 par value

Direct
S · Sale

Shares

−1.93M

Price / share

$16.79

Trade value

$32.44M

% of position

18.9%
3/31/2026
10.24M→8.30M

Class A Ordinary Shares, $0.0001 par value

Direct
S · Sale

Shares

−1.57M

Price / share

$16.79

Trade value

$26.35M

% of position

19.2%
3/31/2026
8.17M→6.60M

Class A Ordinary Shares, $0.0001 par value

Direct
S · Sale

Shares

−248.53K

Price / share

$16.79

Trade value

$4.17M

% of position

19.3%
3/31/2026
1.29M→1.04M
Total

Net shares

−3.75M

Net value

-$62.96M

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)3

Option to Buy

Indirect
Underlying security
Class A Ordinary Shares, $0.0001 par value

Underlying shares

6.68K

Shares owned

6.68K

Exercise price

48.83

Expiration

—

Exercise window

—

Option to Buy

Indirect
Underlying security
Class A Ordinary Shares, $0.0001 par value

Underlying shares

7.69K

Shares owned

7.69K

Exercise price

42.44

Expiration

—

Exercise window

—

Option to Buy

Indirect
Underlying security
Class A Ordinary Shares, $0.0001 par value

Underlying shares

11.30K

Shares owned

11.30K

Exercise price

29.18

Expiration

—

Exercise window

—

Total

Underlying

25.67K

Owned

25.67K